B Begines, T Ortiz, M Pérez-Aranda, G Martínez… - Nanomaterials, 2020 - mdpi.com
The complexity of some diseases—as well as the inherent toxicity of certain drugs—has led to an increasing interest in the development and optimization of drug-delivery systems …
Y Su, B Yu, S Wang, H Cong, Y Shen - Biomaterials, 2021 - Elsevier
In recent years, people have been actively exploring new imaging methods with high biological imaging performance because the clinical image definition and depth in vivo …
Serum albumin, a natural ligand carrier that is highly concentrated and long-circulating in the blood, has shown remarkable promise as a carrier for anti-cancer agents. Albumin is …
FF An, XH Zhang - Theranostics, 2017 - ncbi.nlm.nih.gov
Biosafety is the primary concern in clinical translation of nanomedicine. As an intrinsic ingredient of human blood without immunogenicity and encouraged by its successful clinical …
Y Zhang, T Sun, C Jiang - Acta Pharmaceutica Sinica B, 2018 - Elsevier
Natural biomacromolecules have attracted increased attention as carriers in biomedicine in recent years because of their inherent biochemical and biophysical properties including …
There is progressive evolution in the use of inhalable drug delivery systems (DDSs) for lung cancer therapy. The inhalation route offers many advantages, being non-invasive method of …
Angiogenesis plays a critical role within the human body, from the early stages of life (ie, embryonic development) to life-threatening diseases (eg, cancer, heart attack, stroke, wound …
M Karimi, S Bahrami, SB Ravari… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: One of the biggest impacts that the nanotechnology has made on medicine and biology, has been in the area of drug delivery systems (DDSs). Many drugs suffer from …
The justification of cancer nanomedicine relies on enhanced permeation (EP) and retention (R) effect and the capability of intracellular targeting due primarily to size after internalization …